Ignite Creation Date:
2025-12-24 @ 9:18 PM
Ignite Modification Date:
2025-12-25 @ 7:06 PM
Study NCT ID:
NCT00691704
Status:
COMPLETED
Last Update Posted:
2014-08-19
First Post:
2008-06-03
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Celgene High Risk Multiple Myeloma (MM) Revlimid Induction and Maintenance Therapy
Sponsor:
Cristina Gasparetto
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-08
Start Date Type:
None
Primary Completion Date:
2012-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-05
Completion Date Type:
ACTUAL
First Submit Date:
2008-06-03
First Submit QC Date:
None
Study First Post Date:
2008-06-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-03-04
Results First Submit QC Date:
None
Results First Post Date:
2014-04-10
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-08-14
Last Update Post Date:
2014-08-19
Last Update Post Date Type:
ESTIMATED